Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients

被引：0
|
作者：
Marlies EJ Reinders
Jonna R Bank
Geertje J Dreyer
Helene Roelofs
Sebastian Heidt
Dave L Roelen
Volkert AL Huurman
Jan Lindeman
Cees van Kooten
Frans HJ Claas
Wim E Fibbe
Ton J Rabelink
Johan W de Fijter
机构：
[1] Leiden University Medical Center,Department of Nephrology
[2] Leiden University Medical Center,Einthoven Laboratory for Experimental Vascular Medicine
[3] Leiden University Medical Center,Department of Immuno
[4] Leiden University Medical Center,haematology and blood transfusion
来源：
Journal of Translational Medicine | / 12卷
关键词：
Mesenchymal stromal cells; Renal transplantation; Fibrosis; Immune modulation; Repair;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
    Reinders, Marlies E. J.
    Bank, Jonna R.
    Dreyer, Geertje J.
    Roelofs, Helene
    Heidt, Sebastian
    Roelen, Dave L.
    Huurman, Volkert A. L.
    Lindeman, Jan
    van Kooten, Cees
    Claas, Frans H. J.
    Fibbe, Wim E.
    Rabelink, Ton J.
    de Fijter, Johan W.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [2] Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study
    Marlies E. J. Reinders
    Geertje J. Dreyer
    Jonna R. Bank
    Helene Roelofs
    Sebastiaan Heidt
    Dave L. Roelen
    Maarten L. Zandvliet
    Volkert A. L. Huurman
    Wim E. Fibbe
    Cees van Kooten
    Frans H. J. Claas
    Ton J. Rabelink
    Johan W. de Fijter
    Journal of Translational Medicine, 13
  • [3] Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study
    Reinders, Marlies E. J.
    Dreyer, Geertje J.
    Bank, Jonna R.
    Roelofs, Helene
    Heidt, Sebastiaan
    Roelen, Dave L.
    Zandvliet, Maarten L.
    Huurman, Volkert A. L.
    Fibbe, Wim E.
    van Kooten, Cees
    Claas, Frans H. J.
    Rabelink, Ton J.
    de Fijter, Johan W.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [4] Cardiovascular Effects of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study
    Meucci, Maria Chiara
    Reinders, Marlies E. J.
    Groeneweg, Koen E.
    Bezstarosti, Suzanne
    Ajmone Marsan, Nina
    Bax, Jeroen J.
    De Fijter, Johan W.
    Delgado, Victoria
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (24):
  • [5] Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
    Bank, J. R.
    Rabelink, T. J.
    de Fijter, J. W.
    Reinders, M. E. J.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [6] Bone marrow augmentation in renal transplant recipients
    Shapiro, R
    Starzl, TE
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1371 - 1374
  • [7] Treatment of Renal Transplant Patients with Autologous Bone Marrow Derived Mesenchymal Stromal Cells Downregulates the Donor Specific Mixed Lymphocyte Reaction.
    Reinders, M.
    de Fijter, J.
    Roelofs, H.
    de Vries, D.
    Claas, F.
    van Miert, P.
    Roelen, D.
    van Kooten, C.
    Rabelink, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 340 - 340
  • [8] Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy
    Reinders, Marlies E. J.
    Roemeling-van Rhijn, Marieke
    Khairoun, Meriem
    Lievers, Ellen
    de Vries, Dorottya K.
    Schaapherder, Alexander F. M.
    Wong, San W. S.
    Zwaginga, Jaap Jan
    Duijs, Jacques M.
    van Zonneveld, Anton Jan
    Hoogduijn, Martin J.
    Fibbe, Willem E.
    de Fijter, Johan W.
    van Kooten, Cees
    Rabelink, Ton J.
    Roelofs, Helene
    CYTOTHERAPY, 2013, 15 (06) : 663 - 672
  • [9] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients
    Budde, K.
    Zeier, M.
    Haller, H.
    Arns, W.
    Kramer, S.
    Vogel, E. M.
    Pietruck, F.
    Reinke, P.
    Rath, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 504 - 504
  • [10] ALLOGENEIC, BONE MARROW DERIVED, MESENCHYMAL STROMAL CELLS AS ADJUNCTIVE THERAPY FOR REFRACTORY RENAL ALLOGRAFT REJECTION
    Ashley, Irish
    Raja, Sinniah
    Suda, Swaminathan
    Anne, Warger
    Samantha, Fidler
    Marian, Sturm
    Richard, Herrmann
    IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (08): : A34 - A34
12345